Amniotic Membrane Therapy
Manufactured from human amniotic membrane | Contains collagen I, III, IV, V, VII
이 치료에 대해
Amniotic membrane therapy uses biological material manufactured from placental membrane harvested at birth, implanted into skin. Amniotic membrane contains abundant structural proteins (collagen I, III, IV, V, VII), functioning as natural extracellular matrix. Possesses anti-inflammatory and immunomodulatory effects, excelling in sensitive and inflamed skin.
Amniotic membrane integrates into skin, promoting new collagen formation while gradually absorbing. Functions as biocompatible natural "scaffold" accelerating skin regeneration. Virtually allergy-free from ethically-sourced facilities, offering exceptional safety.
작용 기전
Structural collagen from amniotic membrane (types I, III, IV, V) embedded in dermis functions as physical "scaffold." Fibroblasts migrate along scaffold, promoting collagen production during process. Simultaneously, membrane-contained cytokines (TGF-β, FGF) activate fibroblasts. Anti-inflammatory mucopolysaccharides reduce chronic inflammation, restoring skin barrier function.
적응증
기대 효과
Post-amniotic membrane transplant, skin redness and inflammation significantly reduce. Barrier markers (TEWL, ceramides) improve. Report skin texture enhancement and wrinkle reduction at 3-6 months. Transplant integration rate >90%.
임상 근거
위험 및 부작용
Transplant infection risk (minimal). Virus-negative product screening prerequisite. Allergic reaction rare. Temporary transplant site edema.